Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Getty Images ...

A task force of experts commissioned by the American Academy of Sleep Medicine (AASM) have released updated recommendations for the treatment of central sleep apnea, published in the Journal of ...

Patients with COPD and coexisting OSAS have greater impairments in muscle quality and physical performance than those with isolated COPD.

A new clinical practice guideline developed by a task force of the American Academy of Sleep Medicine provides updated recommendations for the treatment of central sleep apnea. Subscribe to our ...

Maybe you know you snore like a bear, but you don’t feel much urgency to look into it. Or maybe you have been told to wear a continuous positive airway pressure, or CPAP, machine for sleep apnea, but ...

The MarketWatch News Department was not involved in the creation of this content. ATLANTA, Dec. 17, 2025 /PRNewswire/ -- Huxley Medical, Inc. today announced the U.S. Food and Drug Administration (FDA ...

The weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by the U.S. Food and Drug Administration (FDA) to treat obstructive sleep apnea ...

If you have obstructive sleep apnea (OSA), you might be offered a choice between instant breathing support and a long-term approach to target the condition’s root causes. Continuous positive airway ...

Device will not carry concentric collapse contraindication or warning language ...

Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...

The FDA clearance follows the presentation of SANSA clinical performance data earlier this year at the SLEEP meeting. The study, drawing on data collected from 325 patients across 7 clinical sites, ...